熱門資訊> 正文
Q32 Bio任命Lee Kalowski为CFO
2024-04-03 19:26
- Q32 Bio (NASDAQ:QTTB) said it has appointed Lee Kalowski as CFO and president.
- Kalowski brings over two decades of biopharmaceutical experience with a focus on strategy, raising capital, and financial operations.
- Before joining the company in 2023, Kalowski was the finance chief at Bicycle Therapeutics (BCYC)
More on Homology Medicines
- Financial information for Homology Medicines
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。